AdjuTec

AdjuTec Pharma to start phase I trial with APC148

Adjutec is set to start its phase I clinical trial for the enzyme inhibitor APC148, marking a significant milestone...

Intervju

AdjuTec advances towards phase I with regulatory green light

Preparing to hit the clinical stage with its...

Intervju

Adjutec applies for phase I start

Norwegian AdjuTec Pharma prepares for clinical trials with...

Intervju

News round-up Monday, January 15

The latest from BioStock

AdjuTec takes on global antimicrobial resistance

AdjuTec Pharma is determined in its mission to...

News roundup Tuesday, September 12

The latest from BioStock

AdjuTec CEO aims for better and safer antibiotics

Norwegian pharmaceutical company AdjuTec Pharma is on a...

Intervju